jrf30
6 hours ago
ANalyst review of UAMY
United States Antimony Corp. (UAMY)
UAMY: Price: $1.79; Market Cap (M): $202
Rating: Buy; Price Target: $2.60
Heiko F. Ihle, CFA
4Q24 and 2024 Financial Results; Surging Antimony Price Drives Revenue Growth; 2025 Guidance; Reit. Buy; PT Up to $2.60
Click here for complete report and disclosures
On March 20, United States Antimony (UAMY) released its 2024 financial results. During the year, the company recorded $14.9M in revenue, which yielded a net loss of $1.7M, or ($0.02) per share. This compares to 2023 revenue of $8.7M, which yielded a net loss of $6.3M, or ($0.06) per share. Revenue mostly reached our estimate of $15.2M for the year. We note that the 72% YoY revenue increase was driven by the significant growth in the price of antimony following Chinaβs recent export ban. In our view, UAMY should maintain an opportunity to record significant revenue amid strong margins in the coming quarters if worldwide antimony supply from geopolitically safe jurisdictions remains below supply. We also emphasize recent margin improvements, as revenue costs decreased about 5% YoY. Finally, we reiterate our view that UAMY remains well-positioned to invest in its operations and generate significant free cash flow given its cash and cash equivalents balance of $18.2M.
4Q24 financial results. During the quarter, UAMY recorded $6.9M in revenue. 4Q24 revenue came in right around our estimate of $7.1M. The firm ultimately incurred a (largely irrelevant) net loss of $1.1M, or ($0.01) per share. In our view, strong performance during the quarter further showcases UAMY's potential over the coming periods, especially with antimony prices surging in December 2024 after Chinaβs export ban. We anticipate this effect to be felt much more in 2025, since this sharp impact to pricing was just before quarter-end. In contrast, we note ongoing increases to UAMY's cost base as management expands the scope of its operations aggressively. Overall, however, we expect UAMY's recognition of significant revenue to meaningfully benefit and significantly outweigh new expenditures of its growing business.
2025 outlook and near-term plans. Management now expects to reach 2025 revenue of $35.0M - $50.0M, which is right around our prior estimate of $40.0M. We stress that our production forecast is likely in-line with actual production though our estimated pricing may ultimately prove to be conservative. The company is restarting operations at its Madero Smelter in Mexico, with new antimony material and raw antimony inventory expected to arrive at site in the near-term. In addition, we highlight that the necessary improvements to furnaces at Madero have been completed and that the site is likely to further improve UAMYβs production and financial performance during 2025.
We reiterate our Buy rating on UAMY and increase our PT to $2.60 from $2.50. The slight increase to our PT was driven by rolling our DCF forward one year, while also accounting for the company's updated balance sheet. Our valuation for the firm remains based on our DCF of antimony and zeolite operations. We maintain our 12.0% and 15.0% discount rates for these businesses, respectively. We value the companyβs current operations at $312.4M, in addition to a fixed value of $10.0M that we assign to UAMY's Mexican assets and mining claims in Alaska and Ontario. We then add about $18.2M in cash and cash equivalents before subtracting outstanding debt, ultimately giving the firm a total value of $340.0M, or $2.59 per share. We then round this figure to our final PT of $2.60.
Near-term catalysts. Looking ahead, we plan to monitor UAMYβs continued expansion of production during a geopolitically challenged time. We reiterate that our revenue estimate may ultimately prove to be conservative given current spot pricing amid strong demand. We also highlight that the companyβs mining claims in Alaska and Ontario seem to be mostly ignored by the market even as they provide the firm with greater exposure to critical minerals such as cobalt, nickel, copper, and bismuth. Management noted the ongoing turnaround of its firmβs zeolite division, with plant uptime at the site increasing to 98.4% from below 50.0%. The firm has already hired dedicated sales personnel following year-end. In short, we expect to see improvements in revenue and margins for UAMYβs zeolite business going forward, which should ultimately further improve the companyβs financial position.
Risks. (1) Commodity price risk; (2) operational and technical risk; (3) liquidity risk; and (4) political risk.
Heiko F. Ihle, CFA
212-356-0510
hihle@hcwresearch.com
jrf30
22 hours ago
Awesome call just now. Looking to go to Russell 2000 in a few months, adding institutional investors now, demand is growing, revenue up to $14MM and expected about $40MM in 2025, and firing on all cylinders. Looking for more positive movement over the next few months. Oh, and with a market cap of about $195MM, he was asked if it can get to $1B. He not only said yes, but it is basically just a stop on the way for him, and he has done it with every other company he has managed. That's 500% or more above today's price. yea - a good call.
jrf30
3 months ago
I'm amazed the board is still so quiet, even with such a rise. For me, from $0.7758 as my first buy on 12/2 to $2.10 today on 12/16, a mere two weeks!! My average cost basis is much higher, at $1.02 because I kept buying up to about $1.25, but still up over 100% in two weeks. Merry Christmas. Anyway, glad to be on board, wrote the $2.50 calls for extra income, and holding for now. See if they get called away from me. If not, that is another nice gain from the stock. Amazed we are still so dead over here!
jrf30
3 months ago
news for tomorrow
We would like to inform our shareholders and investors that the Chairman and CEO of U.S. Antimony Corporation (NYSE: UAMY), Mr. Gary C. Evans, is being featured tomorrow on Fox Business with Maria Bartiromo at 8:30am Eastern Time, Friday, December 13, 2024.
Viewers can tune in live on FOX Business or visit www.foxbusiness.com for details on the segment.
About United States Antimony Corporation
United States Antimony Corporation (NYSE: UAMY) is a leader in the production and refinement of antimony and zeolite, with a focus on supporting critical industries such as defense, technology, and clean energy. As the only antimony smelter in North America, the company plays a pivotal role in ensuring domestic access to this critical mineral, which is essential for national security and modern manufacturing.
For more information, please visit www.usantimony.com.
jrf30
3 months ago
More news.
On December 10, 2024, MCMANUS MICHAEL A JR, a Director at United States Antimony Corp (UAMY, Financial), purchased 70,000 shares of the company. Following this transaction, the insider now owns a total of 338,333 shares. This purchase is part of a broader trend, as over the past year, the insider has acquired a total of 255,000 shares and has not sold any shares. United States Antimony Corp is engaged in the production and sale of antimony, silver, gold, and zeolite products. The company operates through its subsidiaries and is involved in mining, milling, and smelting operations. The insider transaction history for United States Antimony Corp indicates a positive trend, with 5 insider buys and 0 insider sells over the past year.
db7
2 years ago
probably time to monitor this one imo; mgmt/BOD shakeup... investor call here shortly:
https://www.sec.gov/Archives/edgar/data/101538/000165495423009287/uamy_ex991.htm
THOMPSON FALLS, MT / ACCESSWIRE / July 18, 2023 / United States Antimony Corporation ("USAC"), (NYSE American: UAMY) announces a Company Update / Investor Call for the 18th of July at 2:00 PM Mountain Time (4:00 PM Eastern).
Dial In Information:
Toll free: (888) 506-0062 International: (973) 528-0011
Access code: 160138
Remote Replay available for 7 days:
Toll free: (877) 481-4010
International: (919) 882-2331
Confirmation code /Replay Passcode: 48742
Speakers:
John (Gus) Gustavsen, Chairman & CEO
Gary C. Evans, Lead Director
Joe Bardswich, P.E., Director